Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Oshima

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
JAMA|October 5, 2017
Characteristics of Novel Therapeutics and Postmarket Safety EventsTetsuya Tanimoto, Jinichi Mori, Yasuo Oshima
Experimental Hematology|January 30, 2007
An approach to elucidate potential mechanism of renal toxicity of arsenic trioxideAkira Sasaki, Yasuo Oshima, Akio Fujimura
Annals of Internal Medicine|March 3, 2020
Vibrio vulnificus Infections From a Previously Nonendemic AreaYasuo Oshima, Tetsuya Tanimoto, Koichiro Yuji
Modern Rheumatology|July 18, 2012
Association of hepatitis B with antirheumatic drugs: a case-control studyYasuo Oshima, Hiroshi Tsukamoto, Arinobu Tojo
The New England Journal of Medicine|October 4, 2013
Eculizumab in atypical hemolytic-uremic syndromeTetsuya Tanimoto, Yasuo Oshima, Masahiro Kami
International Journal of Hematology|March 17, 2016
"Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report databaseYasuo Oshima, Koichiro Yuji, Arinobu Tojo
Circulation|February 23, 2017
Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report DatabaseYasuo Oshima, Tetsuya Tanimoto, Koichiro Yuji, et al.
Cytokine|March 16, 2019
Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report databaseYasuo Oshima, Satoshi Takahashi, Kenzaburo Tani, et al.
Annals of Internal Medicine|July 18, 2018
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune DiseaseYasuo Oshima, Noboru Hagino, Masumi Hara, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2018
Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patientsYasuo Oshima, Tetsuya Tanimoto, Koichiro Yuji, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
JAMA|October 5, 2017
Characteristics of Novel Therapeutics and Postmarket Safety EventsTetsuya Tanimoto, Jinichi Mori, Yasuo Oshima
Experimental Hematology|January 30, 2007
An approach to elucidate potential mechanism of renal toxicity of arsenic trioxideAkira Sasaki, Yasuo Oshima, Akio Fujimura
Annals of Internal Medicine|March 3, 2020
Vibrio vulnificus Infections From a Previously Nonendemic AreaYasuo Oshima, Tetsuya Tanimoto, Koichiro Yuji
Modern Rheumatology|July 18, 2012
Association of hepatitis B with antirheumatic drugs: a case-control studyYasuo Oshima, Hiroshi Tsukamoto, Arinobu Tojo
The New England Journal of Medicine|October 4, 2013
Eculizumab in atypical hemolytic-uremic syndromeTetsuya Tanimoto, Yasuo Oshima, Masahiro Kami
International Journal of Hematology|March 17, 2016
"Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report databaseYasuo Oshima, Koichiro Yuji, Arinobu Tojo
Circulation|February 23, 2017
Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report DatabaseYasuo Oshima, Tetsuya Tanimoto, Koichiro Yuji, et al.
Cytokine|March 16, 2019
Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report databaseYasuo Oshima, Satoshi Takahashi, Kenzaburo Tani, et al.
Annals of Internal Medicine|July 18, 2018
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune DiseaseYasuo Oshima, Noboru Hagino, Masumi Hara, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2018
Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patientsYasuo Oshima, Tetsuya Tanimoto, Koichiro Yuji, et al.
Pageof 4